- $883.39m
- $813.37m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
NASDAQ RESUMED AT 09:49 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:44 AM
Brief: Alpha Tau Announces New Research Collaboration To Study The Potential Of Alpha Dart To Enhance Immune Stimulation
Brief: Alpha Tau Announces Completion Of Enrollment Of Japanese Pivotal Clinical Trial In Recurrent Head & Neck Cancer
Brief: Alpha Tau Announces First Patient Enrollment In Combination Trial Of Alpha Dart And Pembrolizumab
Brief: Alpha Tau Announces Completion Of Enrollment In First Us Clinical Trial Of Alpha Dart And Achievement Of First Primary Objective
Healthcare Capital Corp set to open at 4-month high on $1 bln deal with Alpha Tau
Brief: Alpha Tau And Healthcare Capital Corp. To Combine And Create A Publicly Traded Company